HepaRegeniX is developing drugs for treating acute and chronic liver diseases.

Biotechnology

Health Care

Life Sciences

Therapeutics

HepaRegeniX

HepaRegeniX's headquarters in Ulm, Germany

Wolfgang Albrecht

Lars Zender

Emmanuelle Coutanceau

Thomas Knittel

Elias Papatheodorou

Markus Weissbach

Johannes Zanzinger

Sebastian Pünzeler

David Shapiro

The Advisory and Governance Team at HepaRegeniX provides strategic oversight and guidance on corporate governance and decision-making processes. Comprising experienced board members and advisors, the team ensures compliance with regulatory standards, promotes best practices, and facilitates informed organizational governance to support the development of innovative therapies for liver diseases.

Advisory and Governance Team

The Clinical Development Team at HepaRegeniX is responsible for designing and overseeing clinical trials to evaluate the safety and efficacy of new drugs targeting liver diseases. Led by the Chief Medical Officer, the team collaborates with experts in medicinal chemistry and clinical consultancy to ensure compliance with regulatory standards, optimize drug formulations, and advance innovative treatments from early-stage research to market readiness.

Clinical Development Team

The Leadership Team at HepaRegeniX drives the strategic vision and operational execution of the company, focusing on the development of innovative therapies for liver diseases. Comprised of the Chief Scientific Officer and Managing Directors, the team collaborates to oversee research initiatives, ensure regulatory compliance, and guide clinical development pathways, while fostering partnerships to advance the company’s mission.

HepaRegeniX

Org chart

Board & advisors

Teams

Advisory and Governance Team

Clinical Development Team

Leadership Team

Offices

HepaRegeniX

Org chart

Board & advisors

Teams

Advisory and Governance Team

Clinical Development Team

Leadership Team

Offices

Related companies